Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels

American Heart Journal

Volumn 136, Issue 4 I, 1998, Pages 734-740

  Papademetriou, V ^a   Narayan, P ^a   Rubins, H ^a   Collins, D ^a   Robins, S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031760380     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(98)70023-7     Document Type: Article

References (37)

1. WF Enos RN Holmes J. Beyer Coronary disease among United States soldiers killed in action in Korea: preliminary report JAMA 152 1953 1090 1093
2. RL Holman HC McGill Jr JP Strong JC. Geer The natural history of atherosclerosis: the early aortic lesions as seen in New Orleans in the middle of the 20th century Am J Pathol 34 1958 209 235
3. HC McGill Jr. Fatty streaks in the coronary arteries and aorta Lab Invest 18 1968 560 564
4. JP Strong HC McGill Jr. The natural history of coronary atherosclerosis Am J Pathol 40 1962 37 49
5. JP. Strong Coronary atherosclerosis in soldiers: a clue to the natural history of atherosclerosis in the young JAMA 256 1986 2863 2866
6. LA Cupples RB. D’Agostino Survival following initial cardiovascular events. . The Framingham Study: 30-year follow-up 1988 Public Health Service Washington: US NIH Publication No. 88-2909. Section 35
7. WB Kannel DL. McGee Update on some epidemiologic features of intermittent claudication J Am Geriatr Soc 133 1985 13 18
8. TR Dawber WB Kannel N Revotskie J Stokes III A Kagan T. Gordon Some factors associated with the development of coronary heart disease: six years follow-up experience in the Framingham Study Am J Public Health 49 1959 1349 1366
9. FH Epstein LD Ostrander Jr BO Johnson MW Payne NS Hayner JB Keller Epidemiological studies of cardiovascular disease in a total community-Tecumseh, Michigan Ann Intern Med 62 1965 1170 1187
10. J Stamler HA Lindberg DM Berkson A Shaffer W Miller A. Poindexter Prevalence and incidence of coronary heart disease in strata of the labor force of a Chicago industrial corporation J Chron Dis 11 1960 405 420
11. Pooling Project Research Group Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project J Chron Dis 31 1978 201 306
12. WG Hughson JI Mann A. Garrod Intermittent claudication; prevalence and risk factors Br Med J 1 1978 1379 1381
13. JL Jurgens NW Barker EA Hines Jr. Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors Circulation 21 1960 188 195
14. NE Miller DS Thelle OH Forde OD Mjos The Tromso Heart Study: high density lipoprotein and coronary heart-disease: a prospective case control study Lancet 1 1977 968 975
15. MJ Stampfer FM Sacks S Salvini WC Willett CH. Hennekens A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction N Engl J Med 325 1991 373 381
16. GS Ginsburg C Safran RC. Pasternak Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with “desirable” total cholesterol levels Am J Cardiol 68 1991 187 192
17. HB Rubins SJ Robins MK Iwane WE Bodem MB Elam CL Fye Rationale and design for the Department of Veterans Affairs Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density cholesterol Am J Cardiol 71 1993 45 52
18. JR McNamara C Huang T Massov ET Leary GR Warnick HB Rubins Modification of the dextran-MG2+ HDL cholesterol precipitation method for use with previously frozen plasma Clin Chem 40 1994 233 239
19. WT Friedewald RI Levy DS. Frederickson Estimation of the concentrations of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin Chem 18 1972 499 508
20. GD Smith MJ Shipley G. Rose Intermittent claudication, heart disease risk factors, and mortality: the Whitehall study Circulation 82 1990 1925 1931
21. MH Criqui RD Langer A Fronek HS Feigelson MR Klauber TJ McCann Mortality over a period of 10 years in patients with peripheral arterial disease N Engl J Med 326 6 1992 381 385
22. E Varnauskas and the European Coronary Surgery Study Group. Twelve-year follow-up of survival in the randomized European coronary surgery study N Engl J Med 319 1988 332 337
23. KA Eagle CS Rihal ED Foster MC Mickerl BJ Gersh for the CASS Investigators. Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease J Am Coll Cardiol 23 1994 1091 1095
24. LA Solberg JP. Strong Risk factors and atherosclerotic lesions: a review of autopsy studies Arteriosclerosis 3 1983 187 198
25. DM Reed JP Strong J Reash T. Hayashi Serum lipids and lipoproteins as predictors of atherosclerosis: an autopsy study Arteriosclerosis 9 1989 560 564
26. WB Kannel D. Schurtleff The natural history of arteriosclerosis obliterans Cardiovasc Clin 3 1971 317 352
27. JCM Witteman DE Grobbee HA Valkenburg AM van Hemert T Stijnen A. Hofman Cigarette smoking and the development and progression of aortic atherosclerosis: a 9-year population-based follow-up study in women Circulation 88 part 1 1993 2156 2162
28. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report from the pathobiological determinants of atherosclerosis in youth (PDAY) research group JAMA 264 1990 3018 3024
29. R Collins R Peto S MacMahon P Herbert NH Fiebach KA Eberlein Blood pressure, stroke, and coronary heart disease, II: short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context Lancet 335 1990 827 838
30. H. Lithell Pathogenesis and prevalence of atherosclerosis in hypertensive patients Am J Hypertens 7 1994 2S 6S
31. AV Chobanian AH Lichtenstein V Nilakhe CC Haudenschild R Drago C. Nickerson Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit Hypertension 14 1989 203 209
32. WB Robertson JP. Strong Atherosclerosis in persons with hypertension and diabetes mellitus Lab Invest 18 1968 538 551
33. RW. Alexander Theodore Cooper Memorial Lecture: hypertension and the pathogenesis of atherosclerosis Hypertension 25 1995 155 161
34. K. Lundbaek Blood vessel disease Acta Diabetol 8 suppl 1 1971 3 4
35. WB Kannel DL. McGee Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study Diabetes Care 2 1979 920 926
36. WHO Multinational Study of Vascular Disease in Diabetics: prevalence of small vessel and large vessel disease in diabetic patients from 14 centers Diabetologia 28 1985 615 640
37. B Neubauer HJG. Gundersen Calcifications, narrowing, and rugosities of the leg arteries in diabetic patients Acta Radiol 24 1983 401 413